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Abstract
The identification of predictive biomarkers from a large scale of covari-
ates for subgroup analysis has attracted fundamental attention in medical
research. In this article, we propose a generalized penalized regression
method with a novel penalty function, for enforcing the hierarchy struc-
ture between the prognostic and predictive effects, such that a nonzero
predictive effect must induce its ancestor prognostic effects being nonzero
in the model. Our method is able to select useful predictive biomarkers by
yielding a sparse, interpretable, and predictable model for subgroup anal-
ysis, and can deal with different types of response variable such as contin-
uous, categorical, and time-to-event data. We show that our method is
asymptotically consistent under some regularized conditions. To minimize
the generalized penalized regression model, we propose a novel integrative
optimization algorithm by integrating the majorization-minimization and
the alternating direction method of multipliers, which is named after smog.
The enriched simulation study and real case study demonstrate that our
method is very powerful for discovering the true predictive biomarkers
and identifying subgroups of patients.
Availability: The program is available as an R package and can be
downloaded from GitHub (https://github.com/chongma1989/smog).
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1 Introduction
Subgroup analysis has attracted considerable attention in drug development for
identifying patient subgroups that benefit from a greater treatment effect in
various diseases (Lipkovich et al., 2017). Patient subgroups can be determined
by individual baseline characteristics such as demographic, clinical, and genomic
covariates, which we refer to as biomarkers. These biomarkers can be categorized
as predictive or prognostic. Prognostic biomarkers are defined as those that
predict the trajectory of the disease in the absence of treatment, while predictive
biomarkers are defined as those that predict the trajectory of the disease in
response to a particular treatment (Ruberg and Shen, 2015).
Consider, for example, the head and neck squamous cell carcinoma (HN-
SCC) data from The Cancer Genome ATLAS (TCGA) study. which contain
the overall survival time in months and the whole genome expression profiles
of the tumor sample for each of the 510 HNSCC patients. The patients are
dichotomized by whether or not have received radiation therapy, in which 301
patients are with radiation treatment and 209 without. Among the 510 HNSCC
patients, 211 are alive and 299 deceased. Note that the gene expressions were
obtained from the tumor samples of the patients who did not have neo-adjuvant
therapy at the beginning of the cohort study. Figure 1 displays the Kaplan-Meier
curves for the whole HNSCC data, and the biomarker positive subgroup of pa-
tients identified by using the proposed method in this article, respectively. Note
that the treatment effect for the whole HNSCC data is statistically significant
with p-value = 0.005, though it might not be clinically significant. Therefore, it
is intriguing to investigate if there exist predictive genomic biomarkers that can
be used to identify a subgroup of patients who benefit more treatment effect.
Figure 1: Kaplan-Meier curves for the whole HNSCC data and the positive
biomarker subgroup (biomarker (+)) identified by using the proposed method,
respectively. The 95% confidence intervals of relative risks for the radiation
treatment versus no radiation treatment are (0.52, 0.89) and (0.23, 0.51), ac-
cordingly.
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The subgroup analysis and biomarker investigation mainly underlie the vari-
able selection methods by selecting some potential variables from a large scale of
candidate covariates and their interactions with treatment. Penalized regression
methods have been utilized substantially for biomarker study by modeling the
outcome as some link function of the prognostic effects of baseline covariates
and their predictive effects, while imposing on specific penalty function of the
coefficients of the predictor variables for different goals (Imai et al., 2013; Zhao
et al., 2013). Note that the prognostic effects refer to as the main effects of the
baseline covariates, and the predictive effects as the interaction effects of the
baseline covariates with the treatment indicator.
In the general topic of the penalized regression methods, there exists consid-
erably extensive literature for solving various pragmatic and theoretic problems
(Huang et al., 2008; Liu et al., 2012; Meinshausen et al., 2009; Tibshirani, 1996;
Yuan and Lin, 2006). Hierarchical structure models have been studied tremen-
dously for honoring peculiar hierarchy structures between the prognostic and
predictive effects by proposing various penalty functions (Bien et al., 2013; Je-
natton et al., 2010; Zhao et al., 2009). Radchenko and James (2010) proposed
the VANISH method, which is designed for high-dimensional nonlinear problems
by using a penalized least square criterion to enforce the heredity constraint,
that is, if an interaction term is included in the model, then the according main
effects are included automatically. Although VANISH is proved to equip spar-
sistency and persistence properties under some regularity conditions, in practice
it has little chance to select the interaction terms.
Lim and Hastie (2015) proposed an overlapped group-Lasso approach to se-
lect pairwise interactions. Their method augmented and combined the main
effects and the corresponding interaction effects as new groups, conditioning
such constraints that the strong hierarchy structure between the main and in-
teraction effects are satisfied, and then applied the group-Lasso approach (Yuan
and Lin, 2006) for model fitting by using the fast iterative shrinkage-thresholding
algorithm (FISTA) (Beck and Teboulle, 2009). The addition of the original and
augmented main effects are the ultimate estimated main effects in the model.
Lim and Hastie (2015) developed a R pacakge glinternet, which is used to
compete with our developed package smog.
In this paper, we propose a novel penalized regression method for identifying
predictive genomic biomarkers by using a specific penalty function of the prog-
nostic and predictive effects to enforce the specified hierarchy structure (1.1),
that is, if a gene’s predictive effect is nonzero, its corresponding prognostic effect
must be nonzero as well. Note that the treatment effect is not included in the
penalty function.
predictive effect 6= 0 =⇒ prognostic effect 6= 0 (1.1)
In order to deal with various types of response variables such as continu-
ous, categorical, and survival data, the proposed penalized regression method
is adaptively built under the Guaussian, logistic, and Cox proportional hazard
models, respectively. Because the prognostic and predictive effects are over-
lapped in the penalty function, the popular block coordinate descent algorithm
3
(Tseng, 2001) can not be readily applied to minimize the penalized regression
model. To address this issue, we propose a novel optimization algorithm to
integrate the majorization-minimization (MM) (Figueiredo et al., 2007) and the
alternating direction method of multipliers (ADMM) (Tseng, 1991) to solve
the minimization problem in the penalized regression method. Our algorithm
demonstrates more powerful performance in the simulation study and the real
case study.
This paper is organized as follows. We propose our method and algorithm in
Section 2. Section 2.4 introduces several model selection criteria and proposes a
greedy path search for the optimal penalty parameters. We study the asymptotic
property for the proposed method under Gaussian assumption in Section 3. In
Section 4, we conduct various simulation studies to compare our approach with
some existing methods for detecting such genetic biomarkers that satisfies the
hierarchy structure (1.1). We explore our method for some real clinical trial data
in Section 5, and discuss some extended insights and future work in Section 6.
2 Methodology
2.1 Notation
For convenience, we summarize the notations that would be used in the follow-
ing sections. Denote that f(τ,β,γ|data) is the loss function, that is composed
by the negative log-likelihood function for the data under specified model as-
sumptions. The loss function relates the response variable to the addition of
linear terms of the predictors under certain link function, denoted by link(y) ∼
τt+Xβ+Wγ, where t denotes the treatment indicators, X = (x(1), . . . ,x(d))
denotes the matrix of d predictors (genes), and W = (x(1) × t, . . . ,x(d) × t)
represents the matrix of d predictor-by-treatment interactions. Here note that
x(j)×t is the element-wise product between the jth predictor and the treatment
t. We denote that τ is the treatment effect, β = (β1, . . . , βd)
′ are d prognostic
effects, and γ = (γ1, . . . , γd)
′ are d predictive effects, respectively. Denote that
X˜ = (t,X,W ) is the model matrix, and x˜i is the ith row in X˜. θ
′ = (τ,β′,γ′)
represents all parameters to be estimated, ψi = τti+β
′xi+γ′wi represents the
addition of linear terms of the predictors for the ith observation, and φi = e
ψi
denotes the exponential of the linear effects ψi, respectively. Without loss of
generality, we do not include the intercept in the model, since the intercept
would be neglected when fitting the model for centralized data. Thus, the over-
all dimension of the predictors would be p = 2d+ 1.
2.2 Penalized regression models
In this article, the objective function to minimize for generalized penalized mod-
els is
L(τ ,β, λ|data) = f(τ ,β,γ|data) + λΩ(β,γ), (2.1)
4
Where f(τ ,β,γ|data) is the aforementioned loss function for the data, and
λΩ(β,γ) is the penalty function
λΩ(β,γ) =
d∑
j=1
{λ1‖(βj , γj)‖2 + λ2‖(βj , γj)‖22 + λ3|γj |}, (2.2)
Which is a combination of the composition of the group Lasso penalty, ridge
penalty, and Lasso penalty for each group of prognostic (βj) and predictive
(γj) effects. Lemma 1 and lemma 2 prove that the proposed penalty function
enforces the specified hierarchy structure (1.1).
t
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w1
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w2
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Figure 2: Hierarchical structure for genetic biomarkers. A large predictive effect
γ1 would protect its corresponding prognostic effect β1 in the model.
Zhao et al. (2009) proposed the Composite Absolute Penalties (CAP) fami-
lies for selecting groups of predictors by satisfying the provided known hierarchy
structures at the across-group and within-group levels, and suggested using the
BLASSO algorithm to search the CAP regularization path. Hence, our proposed
penalty function can be seen as a specific case of the CAP family.
Nonetheless, the design of the penalty function (2.2) serves exclusively for
detecting predictive biomarkers in drug development, which is compromised
among the model complexity, interpretability, and predictability, respectively.
Notice that the penalty function Ω(β,γ) merely includes the prognostic and pre-
dictive effects of covariates, precluding the penalization of the treatment effect
τ , because the treatment effect should not be penalized in medical research. We
do not include higher order interactions when building the model for controlling
the model complexity. The overlapping of the predictive effect γj between the
group Lasso penalty ‖(βj , γj)‖2 and the Lasso penalty |γj | works for honoring
the hierarchy structure (1.1), which is demonstrated in Lemma 1 and 2. The
ridge penalty aims to improve the consistency of the estimation for the groups
5
of the prognostic and predictive effects βj and γj , when the multicollinearity oc-
curs (Zou and Hastie, 2005). We recommend keep the ridge penalty parameter
λ2 as a fixed tiny value, such as ε = 10
−6 (Bien et al., 2013), and merely tune
the group Lasso penalty parameter λ1 and the Lasso penalty parameter λ3. We
give more details in the greedy pathway search for λ1 and λ3 in Section 2.4.
Figure 2 illustrates the ideal case in which the biomarkers would be selected
by the penalized regression method. When the predictive effect γ2 (the coeffi-
cient for x2 × t) is small, a moderately large λ3 would shrink γ2 to be exactly
zero, while its corresponding prognostic effect β2 (the coefficient for x2) would
be kept in the model, once λ1 is not too large. On the other hand, if a predic-
tive effect γ1 would not be shrunken to be exactly zero, the group Lasso penalty
would keep both of γ1 and its corresponding prognostic effect β1 in the model.
In
We introduce the penalty function used in this article to enforce the hierarchy
structure (1.1), and next we briefly discuss the loss function for various types of
response variable such as continuous, categorical, and time-to-event data. In this
article, we assume that the continuous response variable underlies the Guassian
assumption, the categorical response variable underlies the multinomial logistic
regression model, and the time-to-event response variable underlies the Cox
proportional hazard model, respectively.
(1) Continuous response variable. Assume yi
i.i.d∼ N(ψi, σ2). Thus,
f(τ,β,γ|data) in (2.1) is the common squared-error loss function
1
2
∑n
i=1 (yi − ψi)2, that is,
f(τ ,B,Γ|data) = 1
2
‖y − (τt+
d∑
j=1
(βjx(j) + γjx(j) × t))‖2 (2.3)
(2) Categorical response variable. Suppose that there areK categories for
the response variables. Use the outcome K as the pivot outcome, then the
multinomial regression model under some regularized assumptions gives us
that logit(P (Yi = k)) = τkti+β
′
kxi+γ
′
kwi, i = 1, . . . , n; k = 1, . . . ,K−1.
Hence, the loss function underlying the multinomial logistic regression
model is the negative log-likelihood function
f(τ ,B,Γ|data) =
n∑
i=1
log
(
1 +
K−1∑
k=1
φi,k
)
−
K−1∑
k=1
∑
i∈Gk
ψi,k (2.4)
Where ψi,k = τkti+β
′
kxi+γ
′
kwi, φi,k = e
ψi,k , and θ′k = (τk,β
′
k,γ
′
k) is the
set of regression coefficients associated with outcome k. Note that τ =
(τ1, . . . , τK−1), B = (β1, . . . ,βK−1), and Γ = (γ1, . . . ,γK−1) represent
the combined treatment effects, prognostic effects, and predictive effects,
respectively.
(3) Time-to-event response variable. Let Ti and Ci be the failure
time and censoring time for subject i, i = 1, . . . , n. Define that
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Yi = min{Ti, Ci}, and δi = I(Ti ≤ Ci) is the censoring indicator.
(Yi, δi, x˜i), i = 1, . . . , n is the observed data, and we assume that Ti fol-
lows the Cox proportional hazard model. Note that the hazard func-
tion is h(Yi|x˜i) = h0(Yi)φi. For simplicity, we use the negative partial
log-likelihood function as the loss function to estimate the effect of the
predictors, for avoiding modeling the baseline hazard function h0. The
negative partial log-likelihood function is
f(τ,β,γ|data) =
∑
δi=1
mi−1∑
l=0
log
 ∑
j:Yj≥ti
φj − l
mi
∑
j∈Hi
φj
−∑
j∈Hi
ψj
 (2.5)
Where ti denotes the unique noncensored times, Hi = {Yj : Yj = ti, δj =
1} denotes the set of tied noncensored times, and mi is the size of Hi,
respectively.
So far, we present the penalized regression models for three different types
of response variables. Then we introduce a novel optimization algorithm to
minimize the penalized regression model, and explain why the penalty function
Ω(β,γ) enforces the hierarchy structure (1.1).
2.3 Integrative Optimization Algorithm
Notice that βj and γj are a group of related prognostic and predictive effects
for the predictor xj , and γj is overlapped in the group Lasso penalty ‖(βj , γj)‖2
and the Lasso penalty |γj |, therefore the penalty function Ω(θ) is block separa-
ble between groups of prognostic and predictive effects, rather than component
separable within each group of them. Hence, the minimization problem of the
penalized regression model can not be readily solved by using the block coordi-
nate descent algorithm.
To address this issue, we propose to a novel optimization algorithm by in-
tegrating the Majorization-Minimization (MM) and the alternative direction
method of multipliers (ADMM) to minimize the penalized regression model
L(θ) = f(θ) + λΩ(θ), where f(θ|data) is the loss function, and λΩ(θ) =∑d
j=1
(
λ1‖(βj , γj)‖2 +λ2‖(βj , γj)‖22 +λ3|γj |
)
is the penalty function, which will
be proved to enforce the hierarchy structure (1.1), that is, γj 6= 0 =⇒ βj 6= 0.
In ADMM form, the minimization problem for L(θ) is equivalent to
arg minL(θ) = f(θ) + λΩ(z)
subject to θ = z
(2.6)
Which can be written as the augmented Lagrangian function
L˜(θ, z,u, ρ) = f(θ) + λΩ(z) + u′(θ − z) + ρ
2
‖θ − z‖2, (2.7)
where z is the augmented parameter that is equivalent to θ, u is the dual vari-
able, and ρ > 0 is the penalty for the deviation of θ and z. Given the warm start
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for the parameters θk, zk, uk, the minimization of the augmented Lagrangian
function (2.7) boils down to alternating the minimization with respect to θ, z,
and the dual variable u, respectively, while holding other variables constant,
until the stopping criterion is satisfied such that the primal residual and the
dual residual converge to zero as the algorithm proceeds.
Without loss of generality, assume that f(θ) is a continuously differentiable
convex function with Lipschitz contant L of ∇f(θ). f(θ) can be approximated
by its majorization function using the second-order Taylor expansion at θk, that
is, f(θ) ≤ Q(θ|θk) = f(θk)+∇f(θk)′(θ−θk)+ L2 ‖θ−θk‖2. Then, the (k+1)th
θ-minimization turns out θk+1 = arg minQ(θ|θk) + ρ2‖θ− (zk −uk)‖2. Hence,
θk+1 = 1L+ρ
(
Lθk −∇f(θk) + ρ(zk − uk)). Note that when f(θ) is nonlinear,
it is not trivial to calculate the smallest Lipschitz constant of ∇f(θ) (L). We use
the backtrack line search approach to obtain the smallest Lipschitz constant for
L. To be brief, one can initialize some small value for L and some positive value
α > 1, repeat updating L by scaling it by α until f(θk+1) > Q(θk+1|θk). This
novel optimization algorithm is named for smog, which is designed to minimize
structural models using overlapped group penalty. The overarching steps are
summarized in Algorithm 1.
SMOG Algorithm 1: MM-ADMM for penalized regression models
Input: function f,Ω, and parameters λ, ρ
Initialization for θ0, z0, u0, α > 1;
while εpri > epri or εdual > edual do
Initialization for some L > 0;
repeat
Q(θ|θk) = f(θk) +∇f(θk)′(θ − θk) + L2 ‖θ − θk‖2 ;
Update: L = αL (Backtrack line search for L) ;
until f(θ) ≤ Q(θ|θk);
θk+1 = arg minQ(θ|θk) + ρ2‖θ − (zk − uk)‖2;
zk+1 = arg min ρ2‖z − (θk+1 + uk)‖2 + λΩ(z);
uk+1 = uk + θk+1 − zk+1;
end
Notice that the update of θk+1 is trivial, since the corresponding objective
function Q(θ|θk) + L2 ‖θ − θk‖2 is in quadratic form. The crucial is to update
zk+1, therefore we present the Lemma 1 and 2 to show that the minimizer
zk+1 is fundamentally the proximal operator of the penalty function Ω with
parameter λ/ρ on θk+1 +uk, that is, zk+1 = proxρΩ/λ(θ
k+1 +uk), where uk is
essentially the running sum of the residuals between the original primal variable
θ and the augmented variable z.
Lemma 1. Let θ = (θ1, θ2), b = (b1, b2). The solution to minimize l(θ) =
1
2‖θ − b‖2 + λ1‖θ‖2 + λ2‖θ‖2 + λ3|θ2| with respect to θ is in such form thatθ1 =
1
1+2λ2
(1− λ1√|b1|2+|s(b2,λ3)|2 )+b1
θ2 =
1
1+2λ2
(1− λ1√|b1|2+|s(b2,λ3)|2 )+s(b2, λ3)
(2.8)
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In general, s(b2, λ3) = sign(b2)(|b2| − λ3)+ is the Lasso operator on b2 for the
soft-thresholding parameter λ3, where t+ = max(t, 0).
Proof. Take the derivative for l(θ) with respect to θ1 and θ2 respectively, and
when θ 6= 0, we have{
θ1(1 + 2λ2 +
λ1
‖θ‖2 ) = b1
θ2(1 + 2λ2 +
λ1
‖θ‖2 ) = b2 − λ3sign(θ2)
(2.9)
After taking some simple algebra for (2.9), we obtain ‖θ‖ =
1
1+2λ2
(√|b1|2 + |s(b2, λ3)|2 − λ1)
+
; When
√|b1|2 + |s(b2, λ3)|2 ≤ λ1, θ = 0.
Substitute it back in the formula (2.9), and we can get the solution (2.8).
Remark 1. In Lemma 1, θ1 and θ2 represent the prognostic and predictive
effects, and the penalty term λΩ(θ) = λ1‖θ‖2 + λ2‖θ‖2 + λ3|θ2| realizes the
overlapped penalty on the predictive effect θ2. The three penalty parameters play
their specific roles in this constrained minimization, where λ1 controls to select
or discard θ1 and θ2 together, λ2 can alleviate the multicollinearity between θ1
and θ2, and λ3 controls the selection of θ2.
We can tell from the solution (2.8) that the hierarchy structure θ2 6= 0 =⇒
θ1 6= 0. Because (θ1, θ2) is essentially obtained by applying the group Lasso
operator on (b1, s(b2, λ3)), θ1 and θ2 are selected or discarded simultaneously.
When s(b2, λ3) 6= 0, θ1 6= 0 must come up with θ2 6= 0 for
√|b1|2 + |s(b2, λ3)|2 >
λ1; when s(b2, λ3) = 0, θ2 must be zero but θ1 =
1
1+2λ2
s(b1, λ1), which depends
on λ1.
Lemma 2. Let θ = (τ,β,γ), b = (b0, b1, b2), where τ, b0 ∈ R, and β,γ and
b1, b2 ∈ Rd. Consider the minimization problem
min
θ∈R2d+1
1
2
‖θ − b‖2 +
d∑
j=1
(
λ1‖(βj , γj)‖2 + λ2‖(βj , γj)‖22 + λ3|γj |
)
(2.10)
Where λ1, λ2, λ3 are both positive. The solution to the regularized minimization
problem (2.10) is θ = proxΩ/λ(b) such that
τ = b0
βj =
1
1+2λ2
(1− λ1√
|bj1|2+|s(bj2,λ3)|2
)+b
j
1
γj =
1
1+2λ2
(1− λ1√
|bj1|2+|s(bj2,λ3)|2
)+s(b
j
2, λ3)
(2.11)
j = 1, . . . , d. Note that s(x, λ) = sign(x)(|x| − λ)+ is the lasso soft-threshold
operator for λ > 0.
Proof. Because the objective function (2.10) are separate for τ , (βj , γj), j =
1, . . . , d, thus it can be solved by the block coordinates independently. Note
that the penalty term in the minimization problem (2.10) does not contain
τ , therefore τ = b0. By applying the Lemma 1, we can directly obtain the
solution (2.11).
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Remark 2. Lemma 2 is used for z-update in smog, which realizes the soft-
thresholding by satisfying the hierarchical structure within the groups of (βj , γj).
In fact, we merely apply the Majorization-Minimization algorithm to update
θ one time, but we do not intend to reach the global minimum value for a
temporary objective function f(θ) + ρ2‖θ − (zk − uk)‖2 for updating θ, since
such temporary global minimum value might be trapped in some local minimum
of (2.7). Given the provided absolute and relative tolerance values εabs and εrel
(usually set as 10−4 or 10−5), the stopping criterion in smog requires that the
primal residual εpri = ‖θ
k+1−zk+1‖2√
2p
, and the dual residual εdual = ‖z
k+1−zk‖2√
2p
satisfy that
εpri ≤ epri = εabs + εrel max{‖θ‖
k+1
2√
2p
,
‖z‖k+12√
2p
} (2.12)
εdual ≤ edual =
√
n
p
ρ−1εabs + εrel
‖u‖k+12√
2p
(2.13)
2.4 Tuning the penalty parameter λ
We considered several approaches to determine the optimal penalty parameters
λ. The mean square errors of the response from K-fold cross-validations is a
popular approach to select the best predictive model. One can randomly divide
the data into K folds, where the K − 1 folds of data are used to fit a model,
which is in turn to validate the left one fold data by using the mean square
errors of the response. This approach can be described by using
MSE(λ) =
1
K
K∑
k=1
‖yk − yˆλ(−k)‖2,
where yˆλ(−k) is the fitted response for the kth fold data without using themselves.
A similar approach is the generalized cross-validation score, which is defined as
GCV(λ) =
‖y − yˆλ‖2
n(1− dλ/n)2 .
Note that dλ is the degrees of freedom that is approximated by
tr
{
X˜λ(X˜
T
λ X˜λ +Wλ)
−1X˜λT
}
, where X˜λ is the submatrix with columns cor-
responding to the nonzero coefficients selected by λ, and Wλ is the diago-
nal matrix with the elements that are also determined by the nonzero coeffi-
cients. Because τ is not included in the penalty function, Wλ(τˆ) = 0. And
Wλ(βˆj) =
λ1
‖(βˆj ,γˆj)‖2 + 2λ2 for |βˆj | 6= 0, and Wλ(γˆj) =
λ1
‖(βˆj ,γˆj)‖2 + 2λ2 +
λ3
|γˆj | for
|γˆj | 6= 0, respectively. We also considered the AIC and BIC type criterion to
search the optional λ, such that
AIC(λ) = log(‖y − yˆλ‖2/n) + 2dλ/n,
and
BIC(λ) = log(‖y − yˆλ‖2/n) + log(n)dλ/n.
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In practice, the sample size n is usually small in genetic biomarker study, an
correction AIC criterion is borrowed from Zhao et al. (2009) that is
cAIC(λ) =
n
2
log(‖y − yˆλ‖2) + n
2
(1 + dλ/n)/(1− dλ + 2/n),
in which dλ is used as the number of nonzero predictors.
For simplicity notation, we define c(λ) by the model selection criterion in-
cluding the MSE(λ), GCV(λ), AIC(λ), BIC(λ), and cAIC(λ), respectively.
In Section 4, our simulation study demonstrates that the generalized cross-
validation (GCV) and AIC criteria are likely to select more covariates, which
results in both higher sensitivity and false discovery rate in terms of the true
covariates in the model, and cAIC and BIC are inclined to select smaller number
of covariates, causing the total opposite situation as GCV and AIC. MSE seems
more balanced than other four model assessments, though it is more computa-
tionally expensive. Overall, it is tricky to claim one criterion overwhelmingly
dominates other criteria, therefore we recommend one could consider use both
GCV and MSE criteria under specific conditions.
In practice, it is computationally unfeasible to search a fine grid of points for
three tuning parameters λ1, λ2, λ3 in the elastic-net type penalty term in (2.2).
In Section 2.2, we mentioned that λ2 is recommend to be kept as a fixed tiny
value, such as 10−6, because our simulation study finds that it is preferred by
very small values. In Section 4, for simplicity, we conduct the simulation study
by keeping the ridge penalty parameter λ2 as zero, and the greedy pathway
search merely focuses on tuning λ1 and λ3. Such modification illustrates eas-
ily the power of selecting the true predictive genetic biomarkers. We make it
optional to set λ2 as any constant tiny value in the R package smog.
Jacob et al. (2009) proposed to combine bracketing and golden section search
for univariate λ, however, it is still computationally expensive to do such search-
ing for two λ’s. We propose a greedy pathway search for λ1 and λ3 by entitling
the superiority search in λ1 than λ3, since λ1 controls the selection for groups of
prognostic and predictive effects. Because our proposed algorithm could yield
very sparse estimates for large λ’s fast, it is wisdom to downward search the
optimal λ1 and λ3 from a large value λ0. Hence, start with a large enough
tuning parameter, λ0 = c/λmin(X˜), in which c > 1 ensures that λ0 allows no
more than one predictor entering the model. At the kth search step, define
λ1,k = λ3,k = λ0δ
k, and calculate c1 = c(λ0δ
k+1, λ0δk), c2 = c(λ0δ
k, λ0δ
k+1),
and c3 = c(λ0δ
k+1, λ0δ
k+1), where δ is a fixed arbitrary damping ratio ∈ (0, 1).
At the (k+ 1)th step, λ1,k+1 = λ0δ
k+I(c1∧c3≤c2) and λ3,k+1 = λ0δk+I(c2∧c3<c1).
Continue this pathway search until c(λ1,k+1, λ3,k+1) > c(λ1,k, λ3,k) first occurs.
This greedy pathway search could yield a local minimum for a model selection
criterion at a certain pair of λ1 and λ3, however, it might slip over the local
minimum such that there does not exist a “V” type overturning point for λ1
and λ3. Hence, we recommend set up the maximum search step as 20, and
determine the ultimate λ1 and λ3 with the minimum model selection criterion
value. On the other hand, the pathway search could be substantively affected
by the damping ratio δ, therefore we recommend one could try several damping
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ratios δ’s and choose the pair of λ1 and λ3 with the minimum c(λ1, λ3). We use
δ = 0.9 in the simulation section.
3 Asymptotic properties
In this section, we study the asymptotic property for the penalized regres-
sion model under the Gaussian assumption by using the analogous approach
as Knight et al. (2000). Under the Guassian assumption, the penalized regres-
sion function is
1
2
‖y−
(
τt+
d∑
j=1
(βjx(j) + γjx(j) × t)
)
‖2 +
d∑
j=1
(
λ1‖(βj , γj)‖2 + λ2‖(βj , γj)‖22 + λ3|γj |
)
(3.1)
Before heading the Theorem 1, we denote some additional notations for con-
venience. Denote by X˘ the augmented design matrix for absorbing the ridge
penalty term into the objective function, such that
X˘ =
t X W0 √λ2I 0
0 0
√
λ2I

Denote that u = (u1,u
T
2 ,u
T
3 )
T where u1 is a vector of 1× 1, and u2 and u3 are
vectors of d× 1.
Theorem 1. If λl,n/
√
n → λl ≥ 0(l = 1, 2, 3), and C = limn→∞
(
1
nX˘
T X˘
)
is
nonsingular, then √
n(θˆn − θ)→
d
arg min(V ),
where
V (u) =− uTB + uTCu+ λ1
d∑
j=1
{‖(u2j , u3j)‖2I(‖(βj , γj)‖2 = 0)
+
1
‖(βj , γj)‖ 2
(u2j |βj |+ u3j |γj |)I(‖(βj , γj)‖2 6= 0)}
+ λ3
d∑
j=1
{|u3j |I(γj = 0) + u3jsign(γj)I(γj 6= 0)}
and B has an N (0, σ2C)
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Proof. Define Vn(u) by
Vn(u) =
1
2
{
‖ε− X˘u/√n‖22 − ‖ε‖22
}
+ λ1,n
d∑
j=1
{‖(βj + u2j/√n, γj + u3j/√n)‖2 − ‖(βj , γj‖2}
+ λ3,n
d∑
j=1
{|γj + u3j/√n| − |γj |}
Note that Vn is minimized at
√
n(θˆn − θ), and
1
2
{
‖ε− X˘u/√n‖22 − ‖ε‖22
}
→d −uTB + uTCu
with finite-dimensional convergence holding trivially. We also have
λ1,n
d∑
j=1
{‖(βj + u2j/√n, γj + u3j/√n)‖2 − ‖(βj , γj‖2
→ λ1
d∑
j=1
(‖(u2j , u3j)‖2I(‖(βj , γj)‖2 = 0)
+
1
‖(βj , γj)‖2 (u2j |βj |+ u3j |γj |)I(‖(βj , γj)‖ 6= 0))
and
λ3,n
d∑
j=1
{|γj + u3j/√n| − |γj |} → λ3
d∑
j=1
(|u3j |I(γj = 0) + u3jsign(γj)I(γj 6= 0))
Hence, Vn(u) →d V (u) (as defined above) with the finite-dimensional conver-
gence holding trivially. Because Vn is convex and V has a unique minimum, it
follows (Geyer et al., 1994) that
arg min(Vn) =
√
n(θˆn − θ)→d arg min(V )
Note that when λl = 0, arg min(V ) = C
−1B ∼ N (0, σ2C−1).
Remark 3. In the proof, we assume that d is fixed with n→∞, though it would
be prefered to have d = dn → ∞. For the logistic and Cox proportional hazard
models, the penalized linear regression model is more complex such that we do not
prove the asymptotic property in this article. Under some regularized conditions,
however, we conjecture that the asymptotic property could be extended to the
generalized penalized regression model under the exponential family (Zou, 2006).
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4 Simulation Study
In this section, we conduct extensive simulation studies to evaluate the perfor-
mance of our proposed method in four scenarios by comparing our proposed
method with Lasso, group Lasso, and overlapped group Lasso methods using
the public-known R packages glmnet, gglasso, and glinternet, respectively.
The R package glmnet was established (Friedman et al., 2010; Simon et al.,
2011; Tibshirani et al., 2012) for implementing the Lasso method for various
types of response variable, including the continuous, categorical, time-to-event,
and count data, etc. under different model assumptions, by using coordinate
descent algorithm. Yang and Zou (2015) proposed a groupwise majorization-
descent algorithm for building the software gglasso to solve the group-Lasso
learning problem. glinternet was developed by Lim and Hastie (2015) for
learning pairwise interactions in a linear or logistic regression model by enforcing
the strong hierarchy: a nonzero interaction effect must induce its ancestor main
effects being nonzero.
Table 1: Four scenarios used in the simulation study.
Scenario Description
I
Weak hierarchy: Only includes 5 biomarkers with prognostic effect.
βj = 0.2, γj = 0, j = 1, . . . , 5.
βj = 0, γj = 0, j = 6, . . . , d.
II
Anti-hierarchy: Only includes 5 biomarkers with predictive effect.
βj = 0, γj = 0.2, j = 1, . . . , 5.
βj = 0, γj = 0, j = 6, . . . , d.
III
Strong hierarchy: Includes 5 biomarkers with both prognostic
and predictive effects.
βj = 0.2, γj = 0.2, j = 1, . . . , 5.
βj = 0, γj = 0, j = 6, . . . , d.
IV
Mixture hierarchy: A combination of Model I, II, and III
βj = 0.14, γj = 0, j = 1, . . . , 5.
βj = 0, γj = 0.14, j = 6, . . . , 10.
βj = 0.14, γj = 0.14, j = 11, . . . , 15.
βj = 0, γj = 0, j = 16, . . . , d.
In fact, merely can glinternet compare with our software smog fairly, be-
cause these two software both aim to solve the penalized regression model with
overlapped group penalty for enforcing the hierarchy structure (1.1), though
they are developed by using different algorithms. glmnet and gglasso would
not always honor the hierarchy structure between prognostic and predictive ef-
fects, so that their fitted models lack interpretability. However, it still merits to
study the performance of these softwares on different situations.
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4.1 simulation scenarios
Table 1 displays the four scenarios used in this simulation study. The four sce-
narios are designed based on different hierarchy structures between prognostic
and predictive effects in the model (Bien et al., 2013), which are weak hierarchy,
anti-hierarchy, strong hierarchy, and mixed hierarchy, respectively. The weak
hierarchy refers to as βj 6= 0, γj = 0, the anti-hierarchy is βj = 0, γj 6= 0, the
strong hierarchy is βj 6= 0, γj 6= 0, and the mixed hierarchy contains the three
aforementioned hierarchy structures simultaneously in the model.
In each scenario, the simulation study is conducted underlying different
sample sizes and number of biomarkers, such that n = 100, 200 and d =
200, 500, 1000. Scenario I merely includes 5 biomarkers with prognostic effects
but no predictive effects, scenario II includes 5 biomarkers with predictive effects
but no prognostic effects, scenario III includes 5 markers with both prognostic
and predictive effects, and scenario IV is a combination of scenarios I, II, and
III as in Table 1.
We generate a matrix X of n by p from the standard normal distribution,
and a treatment vector t being either −1 or 1, where 1 represents the treatment
group and −1 for the control group. The way to define the treatment vector
is to allow the variance of the treatment to be 1. For continuous response,
the response variable is generated by adding a linear combination of groups
of prognostic and predictive terms and the Gaussian noise, such as y = τt +∑d
j=1{βjxj + γjxj × t} + ε, where ε follows the Gaussian distribution with
mean 0 and variance-covariance matrix 0.2I. The treatment effect τ is 0.63 for
all four models, while the prognostic and predictive effects for each model are
set as in Table 1. The signal-to-noise ratio (SNR) resulted from prognostic and
predictive effects is set 1, respectively.
For binomial scenario, the response variable is generated by the logistic re-
gression such that P(yi = 1) = 1/(1 + exp(−yi)), where yi is the ith element
in y. For survival case, the response variable is generated based on the Cox
proportional hazard model h(t) = h0(t)exp(y) by using the R package coxed
(Harden and Kropko, 2018), in which the maximum survival time is 100, the
censored ratio is 0.1, and the baseline hazard function is generated using the
default flexible-hazard method as described in Harden and Kropko (2018).
4.2 Accuracy, interpretability, and predictability
For each scenario, we generate a training and testing data in the same way,
where a model is fitted on the training data that is then used to investigate the
prediction power for the testing data. In order to investigate the performances of
different methods on selecting the correct prognostic and predictive biomarkers
from a large number of biomarkers, we calculate the F1 scores for the prognostic
and predictive effects, the hierarchy enforcement rate, and the mean-square
errors on the testing data, respectively.
F1 score is the harmonic average of the sensitivity and the positive predictive
value, where the sensitivity refers to be the proportion of the correct detected
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Table 2: F1 scores for prognostic and predictive effects, hierarchy enforcement rate, and
mean square errors (negative log-likelihood values) for Lasso, group Lasso, Glinternet, and
smog using cross-validation model assessments in four scenarios for continuous and binomial
data.
Continuous:
Scenario n p
Lasso GLasso Glinternet smog(CV)
prog pred hierarchy mse prog pred hierarchy mse prog pred hierarchy mse prog pred hierarchy mse
I
100 200 0.47 0.00 0.01 0.31 0.86 0.00 0.54 0.31 0.38 0.00 1.00 0.29 0.49 0.00 1.00 0.27
100 500 0.40 0.00 0.02 0.35 0.77 0.00 0.50 0.33 0.30 0.00 1.00 0.32 0.46 0.00 1.00 0.30
100 1000 0.36 0.00 0.01 0.37 0.74 0.00 0.58 0.36 0.27 0.00 1.00 0.35 0.44 0.00 1.00 0.32
200 200 0.48 0.00 0.00 0.25 0.94 0.00 0.76 0.25 0.40 0.00 1.00 0.24 0.70 0.00 1.00 0.24
200 500 0.42 0.00 0.00 0.26 0.94 0.00 0.72 0.26 0.33 0.00 1.00 0.25 0.58 0.00 1.00 0.24
200 1000 0.35 0.00 0.00 0.27 0.92 0.00 0.68 0.27 0.27 0.00 1.00 0.26 0.60 0.00 1.00 0.24
II
100 200 0.00 0.43 0.00 0.32 0.00 0.73 0.01 0.34 0.00 0.53 1.00 0.35 0.00 0.53 1.00 0.36
100 500 0.00 0.41 0.00 0.33 0.00 0.68 0.08 0.37 0.00 0.47 1.00 0.38 0.00 0.44 1.00 0.37
100 1000 0.00 0.35 0.00 0.37 0.00 0.59 0.11 0.40 0.00 0.38 1.00 0.42 0.00 0.30 1.00 0.40
200 200 0.00 0.47 0.00 0.25 0.00 0.89 0.00 0.27 0.00 0.57 1.00 0.26 0.00 0.68 1.00 0.27
200 500 0.00 0.41 0.00 0.26 0.00 0.87 0.00 0.28 0.00 0.59 1.00 0.28 0.00 0.70 1.00 0.29
200 1000 0.00 0.38 0.00 0.27 0.00 0.85 0.00 0.29 0.00 0.59 1.00 0.30 0.00 0.74 1.00 0.30
III
100 200 0.34 0.34 0.01 0.44 0.64 0.61 0.22 0.41 0.28 0.52 1.00 0.40 0.55 0.67 1.00 0.42
100 500 0.30 0.29 0.01 0.52 0.61 0.54 0.30 0.49 0.25 0.46 1.00 0.48 0.49 0.57 1.00 0.47
100 1000 0.25 0.24 0.06 0.57 0.55 0.41 0.32 0.55 0.20 0.40 1.00 0.54 0.42 0.47 1.00 0.51
200 200 0.35 0.35 0.00 0.27 0.70 0.74 0.22 0.28 0.29 0.60 1.00 0.27 0.74 0.92 1.00 0.30
200 500 0.30 0.30 0.00 0.30 0.66 0.72 0.18 0.30 0.25 0.64 1.00 0.29 0.66 0.88 1.00 0.31
200 1000 0.25 0.26 0.00 0.33 0.64 0.68 0.14 0.31 0.20 0.59 1.00 0.31 0.70 0.87 1.00 0.32
IV
100 200 0.34 0.33 0.01 0.56 0.47 0.42 0.21 0.56 0.30 0.36 1.00 0.55 0.39 0.33 1.00 0.55
100 500 0.24 0.21 0.03 0.62 0.36 0.26 0.36 0.64 0.22 0.23 1.00 0.62 0.28 0.22 1.00 0.59
100 1000 0.14 0.14 0.02 0.65 0.28 0.15 0.57 0.69 0.14 0.13 1.00 0.64 0.20 0.15 1.00 0.60
200 200 0.41 0.41 0.00 0.35 0.67 0.68 0.00 0.34 0.30 0.56 1.00 0.36 0.58 0.68 1.00 0.42
200 500 0.35 0.35 0.00 0.43 0.61 0.65 0.00 0.39 0.26 0.53 1.00 0.42 0.46 0.55 1.00 0.46
200 1000 0.30 0.30 0.00 0.48 0.58 0.59 0.02 0.42 0.22 0.46 1.00 0.47 0.45 0.46 1.00 0.49
Binomial:
I
100 200 0.30 0.00 0.11 35.75 0.37 0.00 0.94 55.12 0.27 0.00 1.00 34.38 0.33 0.00 1.00 28.35
100 500 0.20 0.00 0.06 36.85 0.36 0.00 0.96 55.72 0.17 0.00 1.00 35.69 0.23 0.00 1.00 28.86
100 1000 0.13 0.00 0.08 38.56 0.35 0.00 0.96 56.41 0.12 0.00 1.00 37.20 0.16 0.00 1.00 30.19
200 200 0.42 0.00 0.02 57.43 0.44 0.00 0.93 106.98 0.34 0.00 1.00 55.36 0.42 0.00 1.00 48.75
200 500 0.34 0.00 0.03 61.43 0.42 0.00 0.94 109.84 0.26 0.00 1.00 59.21 0.35 0.00 1.00 51.94
200 1000 0.28 0.00 0.06 63.46 0.37 0.00 0.92 112.47 0.23 0.00 1.00 61.40 0.31 0.00 1.00 53.46
II
100 200 0.00 0.27 0.02 36.03 0.00 0.03 0.95 57.20 0.00 0.21 1.00 36.71 0.00 0.20 1.00 30.92
100 500 0.00 0.19 0.03 37.32 0.00 0.03 0.94 57.56 0.00 0.13 1.00 38.08 0.00 0.12 1.00 31.01
100 1000 0.00 0.14 0.03 38.66 0.00 0.03 0.94 57.08 0.00 0.08 1.00 39.30 0.00 0.08 1.00 30.86
200 200 0.00 0.41 0.00 57.62 0.00 0.09 0.88 114.58 0.00 0.46 1.00 60.94 0.00 0.45 1.00 55.93
200 500 0.00 0.36 0.01 61.02 0.00 0.05 0.94 117.10 0.00 0.38 1.00 65.67 0.00 0.33 1.00 58.32
200 1000 0.00 0.28 0.02 64.15 0.00 0.04 0.94 117.31 0.00 0.29 1.00 68.33 0.00 0.25 1.00 59.52
III
100 200 0.21 0.21 0.06 36.04 0.40 0.11 0.78 45.79 0.25 0.27 1.00 35.18 0.33 0.34 1.00 35.44
100 500 0.14 0.14 0.05 38.38 0.37 0.09 0.74 47.10 0.15 0.15 1.00 37.94 0.22 0.24 1.00 36.98
100 1000 0.08 0.09 0.07 40.42 0.36 0.06 0.76 47.85 0.09 0.10 1.00 39.82 0.15 0.16 1.00 37.92
200 200 0.34 0.35 0.01 56.97 0.56 0.35 0.54 78.57 0.32 0.47 1.00 54.85 0.48 0.58 1.00 59.41
200 500 0.27 0.27 0.01 62.74 0.52 0.25 0.66 83.36 0.27 0.43 1.00 60.79 0.42 0.51 1.00 64.47
200 1000 0.20 0.22 0.01 65.00 0.44 0.20 0.70 85.92 0.21 0.36 1.00 63.77 0.36 0.43 1.00 67.76
IV
100 200 0.16 0.15 0.06 47.04 0.21 0.03 0.85 56.46 0.17 0.11 1.00 46.59 0.22 0.12 1.00 42.28
100 500 0.09 0.08 0.06 49.42 0.20 0.02 0.83 57.33 0.09 0.04 1.00 48.48 0.12 0.08 1.00 43.09
100 1000 0.05 0.05 0.07 50.18 0.18 0.02 0.89 57.57 0.05 0.03 1.00 49.60 0.08 0.05 1.00 43.68
200 200 0.31 0.32 0.01 80.78 0.24 0.09 0.83 110.55 0.31 0.33 1.00 79.71 0.37 0.28 1.00 78.35
200 500 0.18 0.21 0.04 86.18 0.21 0.06 0.88 113.42 0.19 0.21 1.00 85.53 0.26 0.23 1.00 80.72
200 1000 0.15 0.16 0.06 89.52 0.20 0.03 0.91 113.44 0.15 0.13 1.00 88.62 0.21 0.17 1.00 83.02
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Figure 3: Accuracy of selected predictive effects (F1 score) for continuous and
binary data: n=200, d=1000.
prognostic (predictive) effects to the total number of true prognostic (predictive)
effects, and the positive predictive value refers to be the proportion of the correct
detected prognostic (predictive) effects to the total number of claimed prognostic
(predictive) effects, respectively. F1 score reaches 1 for the perfect case and 0
for the worst. The hierarchy enforcement rate is the proportion of honoring the
hierarchy structure (1.1) over all the repetitions of the simulation, which attains
1 for strictly enforcing the hierarchy, and 0 for fully disobeying. We accordingly
repeat 200 times of the simulation for each of the four scenarios in section 4.1
for continuous, binary, and time-to-event data.
In Section 2.4, we proposed several model assessments and a greedy path
search for the optimal penalty parameters. In the supplemental material, we
investigate the performance of these model assessments using our proposed
method smog, such as the mean squared error of the response in five-fold cross-
validations (CV), the correction AIC (cAIC), AIC, BIC, and the generalized
cross-validation score (GCV), respectively. Comprehensively speaking, these
model assessments have very comparable performances with respect to the F1
scores of prognostic and predictive effects, the hierarchy enforcement rates, and
the predictive power. Obviously, the cross-validation criterion is more compu-
tationally expensive than other model assessments.
Table 2 compare our proposed method using cross-validation model as-
sessment with the competitor methods, such as Lasso, group-Lasso without
honoring hierarchy (GLasso), and group-Lasso with honoring strong hierarchy
(Glinternet) with respect to the F1 scores of prognostic and predictive effect,
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the hierarchy enforcement rate, and the mean squared-error of the testing data,
respectively. Figure 3 displays the accuracy of selected predictive biomarkers
in F1 score for continuous and binary data. Table 2 summarizes for continuous
and binary data, and the relevant simulation results for time-to-event data can
be found in the supplementary file, in which we merely compare our proposed
method with Lasso because neither GLasso nor Glinternet can deal with the
time-to-event data.
Thoroughly speaking, the simulation results demonstrate that our method
smog has very competitive, if not the best, predictive performance than the
competitors in all scenarios for different types of continuous, binary, and time-
to-event data, and smog always strictly obey the hierarchy structures (1.1).
Most importantly, smog dominates, if not overwhelmingly, on the accuracy of
detecting prognostic and predictive effects in most cases, especially, when the
strong hierarchy exists in biomarkers in scenarios III and IV.
On the other hand, in scenario I, when the weak hierarchy lies in biomarkers,
GLasso has somewhat bigger F1 scores for prognostic effects than smog, though
it never strictly obey the hierarchy enforcement. Nonetheless, because GLasso
would select the prognostic and predictive effects simultaneously, higher F1 score
on prognostic effect would select more false predictive biomarkers, while F1
score for predictive effect would be always zero whatever the number of false
predictive biomarkers in that scenario I does not have any predictive biomarker.
In scenario II, smog has better or commensurate performance on the accuracy of
detecting predictive effects than Glinternet, while smog has somewhat smaller
F1 scores than GLasso.
5 Biomarker study and subgroup analysis for
Head and neck cancer
5.1 Head and neck cancer
Head and neck squamous cell carcinoma (HNSCC) is the seventh most frequent
cancer worldwide and accounts for about 4% of all cancers in the United States.
Generally, radiation therapy is a useful treatment for the patients with the HN-
SCC. However, recent research finds that the HNSCC patient population may
have different response to the radiation treatment based on their genetic char-
acteristics. For example, the patients with HPV-positive oropharyngeal tumors
have a better prognosis than those with those with HPV-negative oropharyngeal
tumors. Hence, it is crucial to identify the genetic subpopulation of HNSCC
patients with the radiation treatment effect for the radiation therapy.
5.2 Data Preprocess
We screened and collected 510 HNSCC patients clinical data from the TCGA
and cBioPortal websites, which included 301 patients with radiation therapy
and 209 patients without radiation therapy. The data contained the survival
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information and the whole genomic profile that consist of 20, 531 gene expres-
sions for each patient. In order to better implement our proposed approach,
we preprocessed the gene expression data by removing the genes with missing
values, and merely keeping those genes with the coefficient of variation (CV)
between 0.7 and 10. Then, we took the natural log-transformation on the re-
maining 3, 973 genes and then normalized those gene expressions. To the end,
we fed these normalized 3, 973 genes into our algorithm. For the sake of the
external validation on the performance of our method, we randomly split the
whole data into a learning data set and a validation data set with equal sample
size.
5.3 Biomarker study and subgroup analysis
Fitting on the learning data using our method, we obtained a sparse model
that contained 25 predictive genes with both prognostic and predictive effects,
and 14 prognostic genes with merely prognostic effects. Figure 4 illustrates the
greedy pathway search for the optimal λ1 and λ3 based on the model assessment
GCV, where the minimum GCV is 0.0392 that is obtained at λopt1 = 0.174 and
λopt3 = 0.215. λ2 is kept being zero by default. And the fitted model honors
the hierarchy structure (1.1) such that an existing predictive effect must enforce
the corresponding prognostic effect in the model, and the estimated treatment
effect is −0.001, which should not be penalized during the model fitting. The
details can be seen in the supplementary file.
Notice that most of the 25 predictive genes have negative predictive effects,
which implies that over-expressed these genes could benefit from the radiation
therapy, except SRPX, SPOCK1, and one non-coding gene LOC115165. A lot of
selected genes like KRT13, CDKN2A, EPHX3, PRSS12 are already discovered
to regulate the progression of the head and neck squamous carcinoma cells.
Recent research finds that KRT13 is repressed in oral squamous cell carcinoma,
which may imply over-expressed KRT13 could alleviate the head and neck cancer
(Naganuma et al., 2014). CDKN2A is a tumor-suppressor gene in head and neck
squamous cell carcinoma, which can make p16(INK4A) and p14(ARF) to control
the cell division, and further stimulate or block cell cycle progression (Ai et al.,
2003).
The magnitude of the coefficients in the fitted model is quite small that may
be penalized too much. We refit the training data on the selected 39 genes by
using small penalty parameters such as λ1 = λ3 = 10
−6, which sheds similar
light on the relaxed Lasso (Meinshausen, 2007). The prognostic and predictive
effects for the selected 39 genes are all nonzeros in the refitted model. In order
to investigate the predictive power of the fitted model, we calculate the indi-
vidual treatment contrast (global predictive effect) by multiplying the selected
predictive gene expressions by their corresponding predictive effects, termed zi
for each patient i = 1, . . . , n. We dichotomize all patients into the biomarker-
positive and biomarker-negative groups, where the biomarker-positive group is
{i : zi < 0}, and the biomarker-negative group is {i : zi > 0}, respectively.
Figure 5 demonstrates that the Kaplan-Meier curves for biomarker-positive
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Figure 4: The greedy pathway search for λ1 and λ3 for modeling the head and
neck cancer data based on the model assessment GCV. The minimum GCV
locates at the dark triangle sign, where λopt1 = 0.174 and λ
opt
2 = 0.215, respec-
tively.
subgroup and biomarker-negative subgroup for the training data (first row) and
the testing data (second row), respectively. In the training data, the point esti-
mates and 95% confidence intervals of the relative risk for the positive-biomarker
patients and negative-biomarker patients are 0.18 and (0.09, 0.34), and 2.29
and (1.23, 4.28), respectively; in the testing data, the point estimates and 95%
confidence intervals of the relative risk for the positive-biomarker patients and
negative-biomarker patients are 0.58 and (0.34, 0.99), and 0.87 and (0.51, 1.51),
respectively. There might exist overfitting issues in the training data somewhat,
however, whatever in the training and testing data, the biomarker-positive pa-
tients benefit more from the radiation treatment, yet the biomarker-negative
patients benefit from the control. Collectively, this real case study for HN-
SCC demonstrates that our method is very competitive to detect very powerful
predictive biomarkers for cancer in practice.
6 Discussion
In this article, we propose a novel penalized regression model with a specific
penalty function for enforcing the hierarchy structure between the predictive
and prognostic effects such that a nonzero predictive effect must induce its
ancestor prognostic effect nonzero in the model. For obtaining the minimizer
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Figure 5: Kaplan-Meier curves for the training (first row) and testing (sec-
ond row) HNSCC data. The first row displays the Kaplan-Meier curves for
biomarker-positive and biomarker-negative groups for the training data, where
the 95% confidence intervals of the relative risk for the radiation treatment
versus no radiation treatment are (0.09, 0.34) and (1.23, 4.28), respectively; the
second row represents for the biomarker-positive patients and the biomarker-
negative patients, where the 95% confidence intervals of the relative risks
for the radiation treatment versus no radiation treatment are (0.34, 0.99) and
(0.51, 1.51), respectively.
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of the objective function, we establish an integrative optimization algorithm
by blending the the Majorization-Minimization and the alternating direction
method of multipliers algorithm. We present explicitly the generalized algo-
rithm for different types of response variables such as continuous, categorical,
and time-to-event data, underlying the Gaussian linear model, logistic regres-
sion model, and the Cox proportional hazard model, respectively. We prove the
asymptotic property of the proposed method under the Gaussian linear model,
which could be extended to the generalized linear model in the exponential fam-
ily. We build a R package smog to realize the proposed method, and conduct
enriched simulation study to demonstrate that our method equips the superior
power, compared to the competitors including the Lasso by using the R package
glmnet, the group-Lasso without enforcing the hierarchy structure by using the
R package gglasso, and the group-Lasso with enforcing the hierarchy structure
by using the R package glinternet, etc. We conduct a real case study on head
and neck squamous cell carcinoma (HNSCC) by using our method for detect-
ing the predictive genetic biomarkers and subgroup analysis, and the analysis
result shows that our method is very promosing in pragmatic. In the future
research, we are interested in developing an integrative joint modeling method
in biomarker study for discovering the common predictive genome biomarkers
for different cancer.
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